Josefina Cruz-Jurado

7PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 02, 2026
Biomarkers of prognosis and pazopanib response in soft tissue sarcoma: An exploratory analysis.

|Mar 12, 2026
Safety and Efficacy of Epirubicin, Ifosfamide, and Nivolumab as First-Line Treatment for Patients with Undifferentiated Pleomorphic Sarcoma.

Javier Martin-Broto, Javier Martinez-Trufero, Roberto Diaz-Beveridge

|Feb 24, 2026
Clinical subtypes in breast cancer patients with brain metastases from an ambispective registry of advanced breast cancer, GEICAM/2014-03 (RegistEM).

Sara López-Tarruella, Ángel Guerrero-Zotano, Silvia Antolín

|Mar 10, 2025
Correction: Second-Line Treatment Options for Patients with Metastatic Triple-Negative Breast Cancer: A Review of the Clinical Evidence.

José Ángel García-Saenz, Álvaro Rodríguez-Lescure, Josefina Cruz

|Jan 13, 2025
Second-Line Treatment Options for Patients with Metastatic Triple-Negative Breast Cancer: A Review of the Clinical Evidence.

José Ángel García-Saenz, Álvaro Rodríguez-Lescure, Josefina Cruz

|Sep 09, 2022
Peripheral Inflammatory Indexes Neutrophil/Lymphocyte Ratio (NLR) and Red Cell Distribution Width (RDW) as Prognostic Biomarkers in Advanced Solitary Fibrous Tumour (SFT) Treated with Pazopanib.

Samuel Hidalgo-Ríos, Jaime Carrillo-García, David S Moura

Pageof 2

Frequent Collaborators

3 joint publications

Javier Martin-Broto

2 joint publications

José Ángel García-Saenz

2 joint publications

Jose L Mondaza-Hernandez

2 joint publications

David S Moura